Date:7/23/2009

(72,799) Sales of short-term marketable securities 49,295 19,300 Purchases of long-term marketable securities (17,674) (51,709) Sales of long-term marketable securities 26,975 3,500 Other assets - 543 -- --- Net cash provided by / (used in) investing activities (9,903) (133,107) Financing activities: Payments of long-term liabilities - (300) Issuance of convertible debt, net of costs - 222,414 Purchase of convertible note hedges - (45,758) Sale of warrants - 31,786 Issuance of common stock 6,297 5,356 ----- ----- Net cash provided by financing activities 6,297 213,498 Effect of exchange rate changes on cash 48 - -- - Increase in cash and cash equivalents 4,008 74,309 Cash and cash equivalents at beginning of year 132,318 61,915 ------- ------ Cash and cash equivalents at end of year $136,326 $136,224 ======== ======== Supplemental disclosure of non-cash transactions: Leasehold improvements paid by lessor $2,848

'/>"/>

SOURCE NuVasive, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. NuVasive to Present at the 8th Annual Needham Life Sciences Conference
2. NuVasive to Present at the 2009 William Blair Growth Stock Conference
3. NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
4. NuVasive Reports First Quarter 2009 Financial Results
5. NuVasive Announces Acquisition of Cervical Total Disc Replacement Device
6. NuVasive Announces Conference Call and Webcast of First Quarter 2009 Results
7. NuVasive to Present at Cowen and Company 29th Annual Healthcare Conference
8. NuVasive to Present at Barclays Capital Global Healthcare Conference
9. NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results
10. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
11. NuVasive to Present at Canaccord Adams Musculoskeletal Conference